תבנית:תרופה/אנסטרוזול טבע - Anastrozole teva

× ×ª×× × ×ª×¨××¤×

×××¨×©×

×§×××¦× ×¤×¨××§××××××ª (ATC4)	L02BG Aromatase inhibitors
××¨××× ×¤×¢×× (ATC5)	*Anastrozole 1MG âL02BG03 Anastrozole 1MG âL02BG03 Enzyme inhibitors L02BG âL02BG03 Hamarpeh st.,har hotzvim, jerusalem secondary packaging , primary packaging âL02BG03 18, eli hurvitz street, industrial zone, kfar saba 44102, ISRAEL bulk âL02BG03 Anastrozole 1MG âL02BG03
×¦××¨×ª ××ª×	PER OS
×¦××¨×ª ××× ××	TABLETS
××ª××××	Treatment of advanced breast cancer in post menopausal women. Efficay has not been demonstrated in estrogen receptor negative patients unless they had a previous positive clinical response to tamoxifen. Adjuvant treatment of postmenopausal women with hormone receptor positive early invasive breast cancer. Adjuvant treatment of early breast cancer in hormone receptor positive postmenopausal women who have received 2 to 3 years of adjuvant tamoxifen.
×ª×× ××ª:× ×ª×× × ×¡×/×ª×¨××¤×/×× ×¡××¨×××× ×××¢ - Anastrozole teva
×¢××× ××¨××¤× ×××××¨××ª ××¢×××	××××¨× ××¢×××

×¢××× ××¦×¨××	×¢××× ××¦×¨××

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×× ×¡××¨×××× ×××¢ Â® ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	-
××××¢ ××¨×©×ª	-
×©× ××¦×¨×	TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
×©× ××¢× ××¨××©××	TEVA PHARMACEUTICAL INDUSTRIES LTD, ISRAEL
×¨××©×××	×ª××¨×× ×××©×: 10/2010. ×¨××©××× ××ª××¨××: 07/2014
×ª××¨×× ×¢×××× ×××¨××	14/03/19

××£ ×× × ××¦×¨ ×¢× ××× ××× ××××××¨ ×ª×× ××ª ×¢× ×¤×¨×× ××ª×¨××¤×.

{{×ª×¨××¤×/×× ×¡××¨×××× ×××¢ - Anastrozole teva}}

×:

{{×ª×¨××¤×/×× ×¡××¨×××× ×××¢ - Anastrozole teva
| ×©× ××¤×¨×××¨=×¢×¨× ×××© (×××¨×¡ ××ª ××¢×¨× ×©×××× ×××××¨)
}}

השינוי האחרון נעשה בֹ־14 במרץ 2019 ב־14:28

ויקיתרופות